Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions
NCT00778232
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Gabapentin tablets 800 mg
Sponsor
Ranbaxy Laboratories Limited